Want to see JP:3636 full AI Analyst Report?
Top Page
Mitsubishi Research Institute
(3636)
Select Model
Select Model
Rating:71Outperform
Price Target:
¥5,580.00
▲(14.81% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by strong financial performance and an attractive valuation (low P/E and solid dividend yield). These positives are partly offset by weak technicals, with the stock trading below key moving averages and subdued momentum indicators.
Positive Factors
Improving profitability
Revenue growth combined with improving gross margin and positive EBIT and EBITDA margin trends indicates effective cost management and strengthening operating efficiency. These qualities support more durable profitability across MRI’s research, consulting, and systems-integration activities.
Negative Factors
Declining free-cash-flow growth
Slower free-cash-flow growth and weaker conversion of net income into free cash flow could reduce the funds available for future investments, shareholder returns, or strategic initiatives. If sustained, this may constrain MRI’s ability to translate profitability into financial flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving profitability
Revenue growth combined with improving gross margin and positive EBIT and EBITDA margin trends indicates effective cost management and strengthening operating efficiency. These qualities support more durable profitability across MRI’s research, consulting, and systems-integration activities.
Read all positive factors
Mitsubishi Research Institute (3636) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥78.53B
Dividend Yield3.41%
Average Volume (3M)52.90K
Price to Earnings (P/E)9.2
Beta (1Y)0.69
Revenue Growth9.71%
EPS Growth61.00%
CountryJP
Employees4,695
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)525.61
Shares Outstanding16,044,000
10 Day Avg. Volume38,680
30 Day Avg. Volume52,896
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.13
Price to Sales (P/S)0.67
P/FCF Ratio29.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)420.2
Revenue Forecast (FY)¥126.61B
Mitsubishi Research Institute Business Overview & Revenue Model
Company Description
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, fina...
How the Company Makes Money
MRI primarily generates revenue by delivering fee-based professional services and IT solution projects. A major revenue stream comes from commissioned research and consulting engagements, where clients (including central/local government bodies an...
Mitsubishi Research Institute Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 128.07B | 121.46B | 115.36B | 122.13B | 116.62B | 103.03B |
| Gross Profit | 29.81B | 30.26B | 27.13B | 27.72B | 28.07B | 24.50B |
| EBITDA | 14.91B | 13.72B | 11.74B | 13.40B | 15.80B | 11.48B |
| Net Income | 8.28B | 6.39B | 5.00B | 6.29B | 7.71B | 5.01B |
Balance Sheet | ||||||
| Total Assets | 129.10B | 131.00B | 121.90B | 120.27B | 116.44B | 101.57B |
| Cash, Cash Equivalents and Short-Term Investments | 41.91B | 30.31B | 30.93B | 25.23B | 33.16B | 29.40B |
| Total Debt | 982.00M | 1.04B | 1.11B | 2.09B | 3.53B | 4.93B |
| Total Liabilities | 42.72B | 49.65B | 45.52B | 45.88B | 45.28B | 37.73B |
| Stockholders Equity | 77.22B | 71.92B | 67.63B | 65.80B | 63.05B | 56.28B |
Cash Flow | ||||||
| Free Cash Flow | 2.81B | 2.81B | 12.18B | 3.09B | 7.94B | 2.30B |
| Operating Cash Flow | 6.42B | 6.42B | 13.54B | 5.70B | 9.26B | 3.25B |
| Investing Cash Flow | -4.00B | -4.00B | -2.91B | -2.41B | -6.65B | -1.97B |
| Financing Cash Flow | -3.01B | -3.01B | -4.94B | -6.20B | -3.85B | -4.62B |
Mitsubishi Research Institute Technical Analysis
Positive
4860.00
Price Trends
4780.50
Positive
4695.05
Positive
4756.67
Positive
Market Momentum
85.59
Positive
51.68
Neutral
14.18
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3636, the sentiment is Positive. The current price of 4860 is below the 20-day moving average (MA) of 4975.75, above the 50-day MA of 4780.50, and above the 200-day MA of 4756.67, indicating a neutral trend. The MACD of 85.59 indicates Positive momentum. The RSI at 51.68 is Neutral, neither overbought nor oversold. The STOCH value of 14.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3636.
Mitsubishi Research Institute Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥157.64B | 13.62 | ― | 4.01% | 10.67% | 23.70% | |
75 Outperform | ¥173.10B | 15.12 | 18.62% | 3.46% | 2.62% | 3.56% | |
75 Outperform | ¥32.77B | 9.15 | 10.39% | 5.20% | 3.46% | 6.90% | |
74 Outperform | ¥139.02B | 10.53 | 10.11% | 4.12% | 5.64% | -4.56% | |
71 Outperform | ¥78.53B | 9.21 | ― | 3.46% | 9.71% | 61.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
JP:3636
Mitsubishi Research Institute
4,840.00
139.69
2.97%
JP:9682
DTS
1,091.00
-155.23
-12.46%
JP:9715
transcosmos
3,570.00
34.08
0.96%
JP:4725
CAC Holdings Corporation
1,936.00
-86.27
-4.27%
JP:2317
Systena Corporation
434.00
-51.11
-10.54%
Mitsubishi Research Institute Corporate Events
Mitsubishi Research Institute Delivers Strong Nine-Month Results and Confirms Dividend Outlook
Jul 29, 2026
Mitsubishi Research Institute reported consolidated net sales of ¥98.2 billion for the nine months ended June 30, 2026, up 7.2% year on year, with operating profit rising 14.5% to ¥7.6 billion and profit attributable to owners of parent ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.